Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure

BACKGROUND: For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfortunately, survival is still poor due to distant metastases, which remains the leading cause of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuta, Mojca, Boc, Nina, Brecelj, Erik, Peternel, Monika, Velenik, Vaneja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Clinical and Translational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896420/
https://www.ncbi.nlm.nih.gov/pubmed/33643528
http://dx.doi.org/10.4251/wjgo.v13.i2.119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896420/
https://www.ncbi.nlm.nih.gov/pubmed/33643528
http://dx.doi.org/10.4251/wjgo.v13.i2.119

Ejemplares similares